Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Copenhagen University Hospital, Rigshospitalet
With
Curasight ApS
The sensitivity and specificity of uPAR PET/CT for detection of lymph node metastases will be tested by observer-blinded readings (two separate teams) and compared to diagnostic performance of conventional preoperative diagnostic workup procedures. The reference test will be histopathology of lymph nodes obtained by operative lymph node dissection (SN/ALND). Primary end point dichotomized: +/- lymph node metastases in ipsilateral axilla.
Age
18–85
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Biopsy-verified breast cancer
Primary tumor more than 2 cm (ultrasound or clinically)
The participants must be capable of understanding and giving full informed written consent
You may not be if
Pregnancy
Lactation/breast feeding
Weight above 140 kg
Treatment with neoadjuvant chemotherapy
Known allergy towards the IMP
Clareo Health | uPAR PET/CT for Preoperative Staging of Breast Cancer Patients
